(Total Views: 490)
Posted On: 03/08/2021 12:11:06 PM
Post# of 148903
I wrote Janet.
I don't imagine it will make her change her mind so I focused more on letting her know I was disappointed. Nobody likes to feel like they've let someone down and she deserves to own that feeling. Anyways, here it is in case you care, wish to steal from it, or are just bored.
Hello Mrs. Woodcock.
I'm writing to you about your lack of action, along with your entire team at the FDA, in granting an EUA to Cytodyn's Leronlimab (Vyrologix) for our country's sickest Covid-19 patients.
I don't mean this to sound cruel, but we'll almost surely see over a quarter million American lives lost in the 5-6 months it's going to take to enroll, treat, track, and analyze a whopping 140 additional Leronlimab patients. Probably more than a quarter million lives will be lost, to be honest. And for what? A p-value and power that checks a bureaucratic box more fully? Please help me understand why Leronlimab doesn't deserve an EUA when it meets or exceeds every qualification listed for one by your agency.
I'm just floored by this inaction and I can't begin to express how disappointed I am in you for not using your power and position to do the right thing. It does no harm (as evidenced by 1,000+ patients across many trials and many years) and based on the totality of evidence from EIND and its two trials, it's effective.
Please act now to give the next quarter million American lives about to be lost a fighting chance. It literally can't hurt and can only help. Authorize an EUA for Cytodyn's Leronlimab.
Thank you,
Daytime Respert
I don't imagine it will make her change her mind so I focused more on letting her know I was disappointed. Nobody likes to feel like they've let someone down and she deserves to own that feeling. Anyways, here it is in case you care, wish to steal from it, or are just bored.
Hello Mrs. Woodcock.
I'm writing to you about your lack of action, along with your entire team at the FDA, in granting an EUA to Cytodyn's Leronlimab (Vyrologix) for our country's sickest Covid-19 patients.
I don't mean this to sound cruel, but we'll almost surely see over a quarter million American lives lost in the 5-6 months it's going to take to enroll, treat, track, and analyze a whopping 140 additional Leronlimab patients. Probably more than a quarter million lives will be lost, to be honest. And for what? A p-value and power that checks a bureaucratic box more fully? Please help me understand why Leronlimab doesn't deserve an EUA when it meets or exceeds every qualification listed for one by your agency.
I'm just floored by this inaction and I can't begin to express how disappointed I am in you for not using your power and position to do the right thing. It does no harm (as evidenced by 1,000+ patients across many trials and many years) and based on the totality of evidence from EIND and its two trials, it's effective.
Please act now to give the next quarter million American lives about to be lost a fighting chance. It literally can't hurt and can only help. Authorize an EUA for Cytodyn's Leronlimab.
Thank you,
Daytime Respert
(19)
(0)
Scroll down for more posts ▼